From January 1, 2023 to March 31, 2023, the company has repurchased 263,131 shares, representing 0.55% for $8.01 million. With this, the company has completed the repurchase of 9,002,547 shares, representing 19.1% for $178.77 million under the buyback announced on November 8, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.49 USD | -0.34% | -0.54% | -34.54% |
06-04 | Amphastar Pharmaceuticals, Inc. Approves the Appointment of Howard Lee as Director | CI |
06-04 | Amphastar Pharmaceuticals' Board Approves $50 Million Increase to Share Buyback Plan | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.54% | 1.98B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- AMPH Stock
- News Amphastar Pharmaceuticals, Inc.
- Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016.